- Home
- ACRV vs OMH Comparison
ACRV vs OMH Comparison
Compare ACRV & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- OMH
- Stock Information
- Founded
- ACRV 2018
- OMH 2015
- Country
- ACRV United States
- OMH Singapore
- Employees
- ACRV N/A
- OMH N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- OMH Real Estate
- Sector
- ACRV Health Care
- OMH Finance
- Exchange
- ACRV Nasdaq
- OMH Nasdaq
- Market Cap
- ACRV 41.7M
- OMH 35.8M
- IPO Year
- ACRV 2022
- OMH 2023
- Fundamental
- Price
- ACRV $1.33
- OMH $1.18
- Analyst Decision
- ACRV Buy
- OMH Hold
- Analyst Count
- ACRV 7
- OMH 1
- Target Price
- ACRV $17.40
- OMH N/A
- AVG Volume (30 Days)
- ACRV 213.8K
- OMH 255.1K
- Earning Date
- ACRV 08-13-2025
- OMH 09-24-2025
- Dividend Yield
- ACRV N/A
- OMH N/A
- EPS Growth
- ACRV N/A
- OMH N/A
- EPS
- ACRV N/A
- OMH N/A
- Revenue
- ACRV N/A
- OMH $7,976,578.00
- Revenue This Year
- ACRV N/A
- OMH $28.40
- Revenue Next Year
- ACRV $1,037.93
- OMH $23.07
- P/E Ratio
- ACRV N/A
- OMH N/A
- Revenue Growth
- ACRV N/A
- OMH 117.53
- 52 Week Low
- ACRV $1.05
- OMH $0.59
- 52 Week High
- ACRV $10.16
- OMH $5.46
- Technical
- Relative Strength Index (RSI)
- ACRV 51.00
- OMH 45.60
- Support Level
- ACRV $1.27
- OMH $1.07
- Resistance Level
- ACRV $1.42
- OMH $1.22
- Average True Range (ATR)
- ACRV 0.08
- OMH 0.09
- MACD
- ACRV 0.00
- OMH 0.02
- Stochastic Oscillator
- ACRV 55.32
- OMH 36.67
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.